These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27437390)

  • 1. Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases.
    Jang KU; Kim CW; Kim KH; Lim SB; Yu CS; Kim TW; Kim PN; Kim JH; Kim JC
    Ann Coloproctol; 2016 Jun; 32(3):92-100. PubMed ID: 27437390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens.
    Oussoultzoglou E; Romain B; Panaro F; Rosso E; Pessaux P; Bachellier P; Jaeck D
    Ann Surg; 2009 Jun; 249(6):879-86. PubMed ID: 19474695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic analysis of different treatments for synchronous colorectal liver metastasis].
    Tian Y; Xu X; Gao H; Wang L; Gao Z; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Nov; 18(11):1115-8. PubMed ID: 26616805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
    Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
    World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is complete liver resection without resection of synchronous lung metastases justified?
    Mise Y; Kopetz S; Mehran RJ; Aloia TA; Conrad C; Brudvik KW; Taggart MW; Vauthey JN
    Ann Surg Oncol; 2015 May; 22(5):1585-92. PubMed ID: 25373535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic influence of hepatic margin after resection of colorectal liver metastasis: role of modern preoperative chemotherapy.
    Makowiec F; Bronsert P; Klock A; Hopt UT; Neeff HP
    Int J Colorectal Dis; 2018 Jan; 33(1):71-78. PubMed ID: 29098384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is percutaneous destruction of a solitary liver colorectal metastasis as effective as a resection?
    Marchese U; Seux H; Garnier J; Ewald J; Piana G; Lelong B; Chaisemartin C; Meillat H; Delpero JR; Turrini O
    Ann Hepatobiliary Pancreat Surg; 2021 May; 25(2):198-205. PubMed ID: 34053922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
    Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
    Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Management of Metastatic Colorectal Cancer: A Single-Centre Experience on Oncological Outcomes of Pulmonary Resection vs Cytoreductive Surgery and HIPEC.
    Wong EYT; Tan GHC; Ng DWJ; Koh TPT; Kumar M; Teo MCC
    J Gastrointest Cancer; 2017 Dec; 48(4):353-360. PubMed ID: 27864747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases.
    Nishioka Y; Moriyama J; Matoba S; Kuroyanagi H; Hashimoto M; Shindoh J
    Dig Surg; 2018; 35(3):187-195. PubMed ID: 28848205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection criteria for simultaneous resection in patients with synchronous liver metastasis.
    Minagawa M; Yamamoto J; Miwa S; Sakamoto Y; Kokudo N; Kosuge T; Miyagawa S; Makuuchi M
    Arch Surg; 2006 Oct; 141(10):1006-12; discussion 1013. PubMed ID: 17043279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?
    Ihnát P; Vávra P; Zonča P
    World J Gastroenterol; 2015 Jun; 21(22):7014-21. PubMed ID: 26078580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
    Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
    Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current state of surgical treatment of liver metastases from colorectal cancer.
    Grundmann RT
    World J Gastrointest Surg; 2011 Dec; 3(12):183-96. PubMed ID: 22224173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for multiple bilobar liver metastases of colorectal cancer.
    Shimada H; Tanaka K; Matsuo K; Togo S
    Langenbecks Arch Surg; 2006 Apr; 391(2):130-42. PubMed ID: 16320065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic analysis of colorectal liver metastases treated by surgery combined with intraoperative radiofrequency ablation].
    Mao R; Zhao JJ; Bi XY; Zhao H; Li ZY; Huang Z; Zhang YF; Chen X; Hu HJ; Wu XL; Hu XH; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):521-527. PubMed ID: 28655081
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of timing and cycles of systemic chemotherapy on survival outcome of colorectal liver metastases patients treated by percutaneous microwave ablation.
    Zhang K; Yu J; Zhou F; Yu X; Li X; Wang J; Han Z; Cheng Z; Liang P
    Int J Hyperthermia; 2016 Aug; 32(5):531-8. PubMed ID: 27121037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment Inflammatory Markers Predict Outcomes and Prognosis in Colorectal Cancer Patients With Synchronous Liver Metastasis.
    Li Q; Chen L; Jin H; Zhao Y; Hao Z; Ma X
    Clin Med Insights Oncol; 2022; 16():11795549221084851. PubMed ID: 35355514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic resection after neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer: need for cautious planning.
    Kim YI; Park IJ; Kim JE; Kim SY; Park JH; Lee JH; Ha TY; Hong YS; Kim SY; Kim TW; Lim SB; Yu CS; Kim JC
    Ann Surg Treat Res; 2019 Nov; 97(5):245-253. PubMed ID: 31742209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.
    Pietrantonio F; Di Bartolomeo M; Cotsoglou C; Mennitto A; Berenato R; Morano F; Coppa J; Perrone F; Iacovelli R; Milione M; Alessi A; Vaiani M; Bossi I; Ricchini F; Scotti M; Caporale M; Bajetta E; de Braud F; Mazzaferro V
    Clin Colorectal Cancer; 2017 Sep; 16(3):e191-e198. PubMed ID: 27979717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.